Plex Pharmaceuticals' Corporate Majority Round

Plex Pharmaceuticals raised a round of funding on August 02, 2017. Investors include Collidion.

CalAsia Pharmaceuticals, dba Plex Pharmaceuticals, specializes in early stage Drug Discovery using structure-based drug design. The proprietary technology platform known as Differential Fragment-Based…

Articles about Plex Pharmaceuticals' Corporate Majority Round: